83 related articles for article (PubMed ID: 16973430)
21. Histone acetyltransferase p300 regulates the transcription of human erythroid-specific 5-aminolevulinate synthase gene.
Han L; Lu J; Pan L; Wang X; Shao Y; Han S; Huang B
Biochem Biophys Res Commun; 2006 Sep; 348(3):799-806. PubMed ID: 16904069
[TBL] [Abstract][Full Text] [Related]
22. Nucleolin is involved in interferon regulatory factor-2-dependent transcriptional activation.
Masumi A; Fukazawa H; Shimazu T; Yoshida M; Ozato K; Komuro K; Yamaguchi K
Oncogene; 2006 Aug; 25(37):5113-24. PubMed ID: 16582966
[TBL] [Abstract][Full Text] [Related]
23. Histone deacetylase 3 interacts with and deacetylates myocyte enhancer factor 2.
Grégoire S; Xiao L; Nie J; Zhang X; Xu M; Li J; Wong J; Seto E; Yang XJ
Mol Cell Biol; 2007 Feb; 27(4):1280-95. PubMed ID: 17158926
[TBL] [Abstract][Full Text] [Related]
24. Multiple roles for acetylation in the interaction of p300 HAT with ATF-2.
Karanam B; Wang L; Wang D; Liu X; Marmorstein R; Cotter R; Cole PA
Biochemistry; 2007 Jul; 46(28):8207-16. PubMed ID: 17590016
[TBL] [Abstract][Full Text] [Related]
25. Glucocorticoid-stimulated preadipocyte differentiation is mediated through acetylation of C/EBPbeta by GCN5.
Wiper-Bergeron N; Salem HA; Tomlinson JJ; Wu D; Haché RJ
Proc Natl Acad Sci U S A; 2007 Feb; 104(8):2703-8. PubMed ID: 17301242
[TBL] [Abstract][Full Text] [Related]
26. Cooperation of SRC-1 and p300 with NF-kappaB and CREB in angiotensin II-induced IL-6 expression in vascular smooth muscle cells.
Sahar S; Reddy MA; Wong C; Meng L; Wang M; Natarajan R
Arterioscler Thromb Vasc Biol; 2007 Jul; 27(7):1528-34. PubMed ID: 17495236
[TBL] [Abstract][Full Text] [Related]
27. Postsynaptic chromatin is under neural control at the neuromuscular junction.
Ravel-Chapuis A; Vandromme M; Thomas JL; Schaeffer L
EMBO J; 2007 Feb; 26(4):1117-28. PubMed ID: 17304221
[TBL] [Abstract][Full Text] [Related]
28. Acetylation of the foamy virus transactivator Tas by PCAF augments promoter-binding affinity and virus transcription.
Bodem J; Kräusslich HG; Rethwilm A
J Gen Virol; 2007 Jan; 88(Pt 1):259-263. PubMed ID: 17170459
[TBL] [Abstract][Full Text] [Related]
29. Structure-guided optimization of small molecules inhibiting human immunodeficiency virus 1 Tat association with the human coactivator p300/CREB binding protein-associated factor.
Pan C; Mezei M; Mujtaba S; Muller M; Zeng L; Li J; Wang Z; Zhou MM
J Med Chem; 2007 May; 50(10):2285-8. PubMed ID: 17444627
[TBL] [Abstract][Full Text] [Related]
30. Structure and chemistry of the p300/CBP and Rtt109 histone acetyltransferases: implications for histone acetyltransferase evolution and function.
Wang L; Tang Y; Cole PA; Marmorstein R
Curr Opin Struct Biol; 2008 Dec; 18(6):741-7. PubMed ID: 18845255
[TBL] [Abstract][Full Text] [Related]
31. Targeting of a histone acetyltransferase domain to a promoter enhances protein expression levels in mammalian cells.
Kwaks TH; Sewalt RG; van Blokland R; Siersma TJ; Kasiem M; Kelder A; Otte AP
J Biotechnol; 2005 Jan; 115(1):35-46. PubMed ID: 15607223
[TBL] [Abstract][Full Text] [Related]
32. The two DNA clamps Rad9/Rad1/Hus1 complex and proliferating cell nuclear antigen differentially regulate flap endonuclease 1 activity.
Friedrich-Heineken E; Toueille M; Tännler B; Bürki C; Ferrari E; Hottiger MO; Hübscher U
J Mol Biol; 2005 Nov; 353(5):980-9. PubMed ID: 16216273
[TBL] [Abstract][Full Text] [Related]
33. Cinnamoyl compounds as simple molecules that inhibit p300 histone acetyltransferase.
Costi R; Di Santo R; Artico M; Miele G; Valentini P; Novellino E; Cereseto A
J Med Chem; 2007 Apr; 50(8):1973-7. PubMed ID: 17348637
[TBL] [Abstract][Full Text] [Related]
34. P300 plays a role in p16(INK4a) expression and cell cycle arrest.
Wang X; Pan L; Feng Y; Wang Y; Han Q; Han L; Han S; Guo J; Huang B; Lu J
Oncogene; 2008 Mar; 27(13):1894-904. PubMed ID: 17906698
[TBL] [Abstract][Full Text] [Related]
35. The histone acetyltransferases CBP/p300 are degraded in NIH 3T3 cells by activation of Ras signalling pathway.
Sánchez-Molina S; Oliva JL; García-Vargas S; Valls E; Rojas JM; Martínez-Balbás MA
Biochem J; 2006 Sep; 398(2):215-24. PubMed ID: 16704373
[TBL] [Abstract][Full Text] [Related]
36. Bisubstrate analogue structure-activity relationships for p300 histone acetyltransferase inhibitors.
Sagar V; Zheng W; Thompson PR; Cole PA
Bioorg Med Chem; 2004 Jun; 12(12):3383-90. PubMed ID: 15158807
[TBL] [Abstract][Full Text] [Related]
37. Histone acetyl transferases as emerging drug targets.
Dekker FJ; Haisma HJ
Drug Discov Today; 2009 Oct; 14(19-20):942-8. PubMed ID: 19577000
[TBL] [Abstract][Full Text] [Related]
38. Structural insights into histone H3 lysine 56 acetylation by Rtt109.
Lin C; Yuan YA
Structure; 2008 Oct; 16(10):1503-10. PubMed ID: 18707894
[TBL] [Abstract][Full Text] [Related]
39. [Constructions of Gcn5 shRNAs interfere the histone acetylation modification with stem cell differentiation].
Zhu J; Wang YX; Zhang XP; Wang JJ; Zhang XF; Tian J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Feb; 23(1):43-6. PubMed ID: 16456784
[TBL] [Abstract][Full Text] [Related]
40. Hitting transcription in all the right places.
Lejeune E; Ladurner AG
Nat Struct Mol Biol; 2005 May; 12(5):390-2. PubMed ID: 15870728
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
